07.14.25 -- EU Launches Strategic Bid To Attract R&D And Investments In Biotech

As clinical trials grow increasingly complex, traditional monitoring models are showing their cracks. Overextended CRAs, inconsistent site engagement, and reactive oversight can lead to delays, data quality issues, and strained site relationships. Join clinical operations experts for a candid conversation about what's not working in today’s trial monitoring—and what could.

Without teamwork, the best solutions still fall short. Unlock your clinical data's potential and transform chaos into clarity by starting with clear questions, adapting to insights, and fostering collaboration.

North Carolina's life sciences sector surpasses 100,000 jobs and continues to outpace industry growth. Learn more about the key findings and future opportunities for North Carolina.

Create a simple, modular path to cGMP manufacturing that minimizes risk. Explore a strategic approach for early-stage development and how it can propel therapies to the clinic and the market.

Missed enrollment targets cost millions—TA Scan’s benchmarking and simulation tools empower sponsors to forecast with confidence, optimize site strategy, and keep budgets on track.

A highly concentrated non-aqueous suspension of an IgG1 was developed using a patented platform. Review how the particle size of the mAb impacts the overall behavior of the drug product.